Posted: May 10, 2022 in News
The API team and investigators will work together to design and develop small molecule therapeutics to fight the current and the future variants of coronavirus.......
Posted: May 4, 2022 in News
Andrew MacIsaac, CEO and Director, API visited San Francisco as part of the Edmonton, Alberta delegation for the San Francisco-Edmonton business and tourism trade mission.......
Posted: Apr 28, 2022 in News
Forming an academic-industry collaboration, the project will combine virology expertise of Dr. Anil Kumar, University of Saskatchewan with API’s expertise in drug development to identify......
Posted: Apr 26, 2022 in Newsletter
Hi everyone, I hope you are having a wonderful April! We’re excited to participate in some interesting events, committees, and delegations this year. In addition......
Posted: Apr 25, 2022 in Blog
Any drugs or therapeutics with a potential to become real treatment and ultimately improve patient outcomes, are required to go a regulatory approval process. This......
Posted: Apr 22, 2022 in News
Micheal Guirguis, Director, Clinical Pharmacology & Data and member of API’s senior leadership team visited Calgary this week to be a part of the Alberta......
Posted: Apr 15, 2022 in News
Members of API’s senior leadership team Hana Marinkovic, Director of Corporate Affairs and Micheal Guirguis, Director, Clinical Pharmacology & Data visited Nashville as part of the......
Posted: Apr 12, 2022 in Events
The 2022 Executive Summit Series by Canadian Chamber of Commerce will feature six sectors and will explore how each contributes to our country’s economic success.......
Posted: Apr 5, 2022 in Events
API is participating in Alberta Economic Development Leaders’ Summit & Conference by Economic Developers Alberta (EDA) happening on April 06-08. The conference will bring together industry......
Posted: Mar 31, 2022 in News
Through this academic and industry collaboration, the partners will create a rich training environment for students and postdoctoral fellows, strengthen antiviral drug discovery pipeline against......
Posted: Mar 29, 2022 in Blog
Life Science organizations and entrepreneurs are innovators who make life-changing and life-saving treatments. The work is incredibly rewarding but what keeps people going? In a......
Posted: Mar 22, 2022 in News
Edmonton, AB. March 22, 2022: We’re thrilled to announce that BioAlberta has recognized Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton in......
Sign up to receive industry updates and news from API.